VARTAN BEKERIAN: Open Payments
NPI 1790558187 · CULVER CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 65 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $922 · 2025 $1,762
Food & beverage: $1,762
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 37 | $935 |
| Alkermes, Inc. | 15 | $333 |
| Otsuka America Pharmaceutical, Inc. | 1 | $146 |
| Neurocrine BioSciences, Inc. | 7 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
Products named: INVEGA SUSTENNA, ARISTADA, ABILIFY MAINTENA, LYBALVI, INGREZZA, COBENFY, CAPLYTA, FANAPT.
Industry payments across CA — which companies pay providers there.
